bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.675
+0.004 (0.55%)
Jan 21, 2025, 4:00 PM EST - Market closed
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $10.52 million as of January 21, 2025. Its market cap has decreased by -27.18% in one year.
Market Cap
10.52M
Enterprise Value
11.09M
1-Year Change
-27.18%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $10.52M, a decrease of -76.62%. That is a compound annual growth rate of -45.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 10.52M | -25.82% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |